Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Galeazzi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|December 5, 2019
A Novel Fully-Human Potency-Matched Dual Cytokine-Antibody Fusion Protein Targets Carbonic Anhydrase IX in Renal Cell CarcinomasRoberto De Luca, Baptiste Gouyou, Tiziano Ongaro, et al.
Biomacromolecules|December 5, 2009
Multivalent supramolecular dendrimer-based drugsSimone Galeazzi, Thomas M Hermans, Marco Paolino, et al.
Journal of Medicinal Chemistry|October 27, 2006
Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffoldsAndrea Cappelli, Gal la Pericot Mohr, Germano Giuliani, et al.
Journal for Immunotherapy of Cancer|September 14, 2022
Generation and <i>in vivo</i> validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibodyLisa Nadal, Frederik Peissert, Abdullah Elsayed, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|December 5, 2019
A Novel Fully-Human Potency-Matched Dual Cytokine-Antibody Fusion Protein Targets Carbonic Anhydrase IX in Renal Cell CarcinomasRoberto De Luca, Baptiste Gouyou, Tiziano Ongaro, et al.
Biomacromolecules|December 5, 2009
Multivalent supramolecular dendrimer-based drugsSimone Galeazzi, Thomas M Hermans, Marco Paolino, et al.
Journal of Medicinal Chemistry|October 27, 2006
Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffoldsAndrea Cappelli, Gal la Pericot Mohr, Germano Giuliani, et al.
Journal for Immunotherapy of Cancer|September 14, 2022
Generation and <i>in vivo</i> validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibodyLisa Nadal, Frederik Peissert, Abdullah Elsayed, et al.
Pageof 1